http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008182812-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5e9c4dcdef8a30f9e033d723859c3ff |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0362 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0276 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711 |
| filingDate | 2008-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f2b96c6ec2539c4a1718c0cc9210602 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f79ed2d234fc91d59946b67c2a0e897 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c575e44ff3a25b57c38ea616ddc99040 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b7f6585477caf87164d9ee7f2f6a1e4 |
| publicationDate | 2008-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2008182812-A1 |
| titleOfInvention | Disease model animals of metabolic syndrome and a method of screening preventive and therapeutic agents for metabolic syndrome using the same |
| abstract | The object of the invention is to provide animal model of disorder and method of screening an agent for preventing or treating Metabolic Syndrome by using the animal model, wherein said animal model is used as experimental material which is essential to detailed analysis of component and pathologic condition of Metabolic Syndrome and to development of the method for treating and the agent for preventing and treating the Metabolic Syndrome. n The above object is achieved by the non-human mammal model of disorders, whose TBP-2 gene is functionally deficient on chromosome, wherein the disorders are caused by impaired fatty acid utilization, and a method of screening an agent for preventing or treating Metabolic syndrome comprising; administering a test article to the non-human mammal whose TBP-2 gene is functionally deficient on chromosome. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012058105-A1 |
| priorityDate | 2006-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 569.